glucagon-like peptide 2



glucagon-like peptide 2

H1HH1A2AA2D3DD3G4GG4S5SS5F6FF6S7SS7D8DD8E9EE9M10MM10N11NN11T12TT12I13II13L14LL14D15DD15N16NN16L17LL17A18AA18A19AA19R20RR20D21DD21F22FF22I23II23N24NN24W25WW25L26LL26I27II27Q28QQ28T29TT29K30KK30I31II31T32TT32D33DD33

SMILES None
InChIKey TWSALRJGPBVBQU-PKQQPRCHSA-N
Sequence HADGSFSDEMNTILDNLAARDFINWLIQTKITD

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


Bioactivities

glucagon-like peptide 2

H1HH1A2AA2D3DD3G4GG4S5SS5F6FF6S7SS7D8DD8E9EE9M10MM10N11NN11T12TT12I13II13L14LL14D15DD15N16NN16L17LL17A18AA18A19AA19R20RR20D21DD21F22FF22I23II23N24NN24W25WW25L26LL26I27II27Q28QQ28T29TT29K30KK30I31II31T32TT32D33DD33

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.